These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5002660)

  • 1. Metabolism of radiolabelled C'3 and C'4 in human renal allograft recipients.
    Carpenter CB; Ruddy S; Shehadeh IH; Merrill JP; Austen KF; Muller-Eberhard HJ
    Transplant Proc; 1969 Mar; 1(1):279-82. PubMed ID: 5002660
    [No Abstract]   [Full Text] [Related]  

  • 2. The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.
    Müllerèberhard HJ; Dalmasso AP; Calcott MA
    J Exp Med; 1966 Jan; 123(1):33-54. PubMed ID: 4159289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia.
    Petz LD; Fink DJ; Letsky EA; Fudenberg HH; Müller-Eberhard J
    J Clin Invest; 1969 Nov; 47(11):2469-84. PubMed ID: 4975569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.
    da Silva WD; Eisele JW; Lepow IH
    J Exp Med; 1967 Dec; 126(6):1027-48. PubMed ID: 6069927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Behavior of the 3rd and 4th complement fractions (C'3 and C'4) in hepatic cirrhosis].
    Díaz-Rubio García M; Enríquez L; Erroz A; Arroyo MJ; Zamarrón A; Díaz-Rubio García C; Díaz Rubio M
    Rev Clin Esp; 1974 Aug; 134(4):319-22. PubMed ID: 4445539
    [No Abstract]   [Full Text] [Related]  

  • 6. THE ROLE OF THE COMPONENTS OF COMPLEMENT IN SPECIFIC IMMUNE FIXATION.
    Pillemer L; Seifter S; Ecker EE
    J Exp Med; 1942 Apr; 75(4):421-35. PubMed ID: 19871194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular ultrastructure and macromolecular permeability following human renal transplantation.
    Hulme B; Porter KA; Ogden DA
    Transplant Proc; 1969 Mar; 1(1):271-4. PubMed ID: 5002659
    [No Abstract]   [Full Text] [Related]  

  • 8. Alterations in human serum beta-1C-gobulin (C'3) in renal transplantation.
    Carpenter CB; Gill TJ; Merrill JP; Dammin GJ
    Am J Med; 1967 Dec; 43(6):854-67. PubMed ID: 4169206
    [No Abstract]   [Full Text] [Related]  

  • 9. A specific inactivator of mammalian C'4 isolated from nurse shark (Ginglymostoma cirratum) serum.
    Jensen JA
    J Exp Med; 1969 Aug; 130(2):217-41. PubMed ID: 4893886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation antibody associated with first-set renal homografts.
    Spong FW; Feldman JD; Lee S
    J Immunol; 1968 Sep; 101(3):418-25. PubMed ID: 4970959
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of the fractions of complement (C'1, C'2, C'3, C'4) in hypocomplimentary glomerulopathies].
    Lagrue G; Brécy H; Bariéty J; Milliez P; Hartmann L
    Rev Fr Etud Clin Biol; 1967 Dec; 12(10):990-5. PubMed ID: 5598513
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the mechanism of canine renal allograft rejection.
    Foker JE; Clark DS; Pickering RJ; Good RA; Varco RL
    Transplant Proc; 1969 Mar; 1(1):296-300. PubMed ID: 4944231
    [No Abstract]   [Full Text] [Related]  

  • 13. Levels of wo components of complement (C'4 and C'3) in human fetal and newborn sera.
    Adinolfi M
    Dev Med Child Neurol; 1970 Jun; 12(3):306-8. PubMed ID: 5433147
    [No Abstract]   [Full Text] [Related]  

  • 14. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.
    Alper CA; Rosen FS
    J Clin Invest; 1967 Dec; 46(12):2021-34. PubMed ID: 6074005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of the total complement activity of serum and of 4 fractions: C'1, C'2, C'3, C'4].
    Brécy H; André A; Hartmann L
    Rev Fr Etud Clin Biol; 1967 Dec; 12(10):1024-8. PubMed ID: 5598511
    [No Abstract]   [Full Text] [Related]  

  • 16. Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.
    Müller-Eberhard HJ; Polley MJ; Calcott MA
    J Exp Med; 1967 Feb; 125(2):359-80. PubMed ID: 6019133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modification of complement factors and their inhibitors during meningococcal sepsis (author's transl)].
    Blanco A; Solís P; Alvarez Guisasola FJ; Valbuena C; Gómez C; Prieto P; Ruíz C
    An Esp Pediatr; 1980 Aug; 13(8):679-88. PubMed ID: 7436149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological determination of C'3 and C'4 in various morbid conditions].
    Stangalini A
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1973; 66(1):121-8. PubMed ID: 4777521
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serum complement and C'1, C'2, C'3 and C'4 components in rheumatoid arthritis and collagen diseases].
    Pietruska Z
    Pol Tyg Lek; 1972 Dec; 27(51):2010-3. PubMed ID: 4653713
    [No Abstract]   [Full Text] [Related]  

  • 20. [Irregular behavior of complement in coeliac disease (author's transl)].
    Blanco A; Alonso M; Solís P; Calvo C; Catoira A; Sánchez Villares E
    An Esp Pediatr; 1981 Nov; 15(5):449-54. PubMed ID: 7332146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.